Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.
Hardwick NR, Frankel P, Ruel C, Kilpatrick J, Tsai W, Kos F, Kaltcheva T, Leong L, Morgan R, Chung V, Tinsley R, Eng M, Wilczynski S, Ellenhorn JDI, Diamond DJ, Cristea M. Hardwick NR, et al. Among authors: cristea m. Clin Cancer Res. 2018 Mar 15;24(6):1315-1325. doi: 10.1158/1078-0432.CCR-17-2709. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301826 Free PMC article. Clinical Trial.
Targeted agents in ovarian cancer.
Kristedja TS, Morgan RJ, Cristea M. Kristedja TS, et al. Among authors: cristea m. Womens Health (Lond). 2010 Sep;6(5):679-94. doi: 10.2217/whe.10.48. Womens Health (Lond). 2010. PMID: 20887168 Free article. Review.
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
Portnow J, Frankel P, Koehler S, Twardowski P, Shibata S, Martel C, Morgan R, Cristea M, Chow W, Lim D, Chung V, Reckamp K, Leong L, Synold TW. Portnow J, et al. Among authors: cristea m. Cancer Chemother Pharmacol. 2012 Feb;69(2):505-14. doi: 10.1007/s00280-011-1721-x. Epub 2011 Aug 18. Cancer Chemother Pharmacol. 2012. PMID: 21850464 Free PMC article. Clinical Trial.
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors.
Koczywas M, Frankel PH, Synold TW, Lenz HJ, Mortimer JE, El-Khoueiry AB, Gandara DR, Cristea MC, Chung VM, Lim D, Reckamp KL, Lau DH, Doyle LA, Ruel C, Carroll MI, Newman EM. Koczywas M, et al. Among authors: cristea mc. Br J Cancer. 2014 Dec 9;111(12):2268-74. doi: 10.1038/bjc.2014.554. Epub 2014 Oct 28. Br J Cancer. 2014. PMID: 25349975 Free PMC article. Clinical Trial.
Overcoming immunosuppression to enhance a p53MVA vaccine.
Hardwick N, Chung V, Cristea M, Ellenhorn JD, Diamond DJ. Hardwick N, et al. Among authors: cristea m. Oncoimmunology. 2014 Dec 15;3(10):e958949. doi: 10.4161/21624011.2014.958949. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941580 Free PMC article.
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.
Reckamp KL, Koczywas M, Cristea MC, Dowell JE, Wang HJ, Gardner BK, Milne GL, Figlin RA, Fishbein MC, Elashoff RM, Dubinett SM. Reckamp KL, et al. Among authors: cristea mc. Cancer. 2015 Sep 15;121(18):3298-306. doi: 10.1002/cncr.29480. Epub 2015 May 29. Cancer. 2015. PMID: 26033830 Free PMC article. Clinical Trial.
221 results